Shandong Huashang Chemical Co., Ltd.
Product
Tesamorelin (usan)
  • Brand:HuaShang
  • Model:25kg/drum
  • Purity:99%
  • Cas:218949-48-5
  • Createtime: 2026-04-14
  • Updatetime: 2026-04-15
Product Details
useage Industrial use
deliveryInfo
appearance powder
Storage Store tightly sealed at -20 °C and protected from light. Aqueous solution can be stored at -80 °C for up to six months.
aliasen
supplyCapacity 50000Metric Ton/Month
Solubility Soluble in water and dilute acid; insoluble in common organic solvents
harbor Qingdao,China
minorder 1KG
Transport Transport under cold chain with ice packs
  1. Appearance: White lyophilized powder
  2. Assay: 98.0–101.0% (HPLC)
  3. Water Content: ≤5.0% (KF titration)
  4. Related Substances: ≤2.0% (HPLC)
  5. Sterility: Complies with sterility requirements
  6. Endotoxin: ≤0.1 EU/mg


Application

Tesamorelin is a long-acting synthetic growth hormone-releasing hormone analog. It functions by stimulating the pituitary gland to secrete growth hormone and elevate the level of insulin-like growth factor-1 in the human body. It is primarily applied for the treatment of HIV-associated lipodystrophy, effectively reducing visceral adipose tissue and optimizing body fat distribution. In pharmaceutical research, this compound serves as a core research material for studying growth hormone deficiency, obesity, metabolic syndrome and sarcopenia. It is also widely used in anti-aging research and sports medicine to explore mechanisms related to muscle synthesis, fat metabolism and physical recovery. As a highly active peptide reagent, it is extensively adopted in GHRH receptor binding tests, cellular signal pathway analysis and structure-activity relationship studies. It provides reliable support for the research and development of new therapeutic drugs targeting metabolic disorders, and plays an indispensable role in preclinical pharmacological experiments and academic exploration.

Safety Information

Tesamorelin is a prescription biopharmaceutical product, which shall only be handled and used by qualified laboratories and medical institutions. Subcutaneous or intravenous administration may cause local reactions at injection sites, accompanied by headache, nausea, mild edema and blood sugar fluctuation. In rare cases, severe allergic reactions and symptoms similar to acromegaly caused by excessive growth hormone secretion may occur. It is contraindicated for pregnant women, breastfeeding women, patients with malignant tumors and those suffering from severe liver and kidney dysfunction. All operations must follow aseptic techniques. Wear protective gloves, safety goggles and face masks to prevent inhalation of powder and direct contact with skin or mucous membranes. Keep the product sealed away from heat sources and oxidants during storage. All waste materials and contaminated containers shall be disposed of strictly as biohazard waste in accordance with local regulations. Avoid improper use and cross-contamination to eliminate potential health risks.